On a DART-filed basis, revenue fell from KRW 100.4 billion in 2022 to KRW 18.2 billion in 2023, a decline of 81.8%, and then to KRW 15.6 billion in 2024 (down 14.3%) and KRW 11.2 billion in 2025 (down 28.2%), extending a three-year decline. Among the years from 2022 to 2025, 2022 was the largest and 2025 the smallest.
The operating loss was KRW 14.6 billion in 2022, narrowed to KRW 5.16 billion in 2023, widened to KRW 5.54 billion in 2024 and to KRW 6.53 billion in 2025. The operating margin moved from -14.6% in 2022 to -28.3% in 2023, -35.4% in 2024 and -58.2% in 2025, as revenue shrank faster than losses could be reduced.
Net loss attributable to controlling shareholders was KRW 23.1 billion in 2022, turned to a net profit of KRW 8.07 billion in 2023, returned to a net loss of KRW 6.97 billion in 2024 and widened to KRW 13.1 billion in 2025.
Total net income including non-controlling interests was a loss of KRW 33.7 billion in 2022, so the two measures diverge in that year. The company cited lower revenue, higher cost of sales and larger valuation losses on derivatives as the main reasons for the 2025 net loss.
In October 2025 the company said it recovered US$6.7 million, about KRW 9.6 billion, from its Israeli joint venture Quntrigen, producing a gain of KRW 2.4 billion over book value, but how that gain was reflected in the 2025 results cannot be separated from the filed figures.
Quarterly revenue rose from KRW 1.18 billion in the third quarter of 2025 to KRW 4.61 billion in the fourth quarter, a rise of 290.3%, then fell to KRW 2.33 billion in the first quarter of 2026, down 49.5%, held at KRW 2.34 billion in the second quarter and was KRW 1.15 billion in the third quarter of 2026, down 3.0% from a year earlier.
The operating loss was KRW 1.36 billion, KRW 1.23 billion and KRW 1.28 billion in the first three quarters of 2026, and the third-quarter 2026 net profit attributable to controlling shareholders of KRW 494 million followed a net loss of KRW 7.91 billion in the prior quarter.
The aggregate net loss attributable to controlling shareholders over the last four quarters was KRW 12.5 billion.